NCT01500057

Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia

An Open-Label Randomized Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Brooklyn Urology Research Group · Academic / Other
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This is a Phase 4, prospective, open-label, randomized study of Greenlight XPS Laser versus BiVAP Saline Vaporization of the prostate in men with symptomatic Benign Prostatic Hyperplasia (BPH). The study consists of a screening phase, treatment, followed by follow-up visits at 1 week, 4 weeks, 3 months, 6 months, and 12 months.

Conditions

• Benign Prostatic Hyperplasia (BPH)

Interventions

Type	Name	Description
DEVICE	Greenlight XPS Laser	Treatment of BPH with Greenlight XPS laser
DEVICE	BiVAP Saline Vaporization of the prostate	treatment of BPH with BiVAP Saline Vaporization

Timeline

• Start date: 2011-12-01
• Primary completion: 2016-10-10
• Completion: 2016-10-10
• First posted: 2011-12-26
• Last updated: 2018-05-14
• Results posted: 2018-05-14

Locations

1 site across 1 country: United States